Not Signed In - FDA Approves Higher Dose Formulations Of Diovan HCT(R) (valsartan/hydrochlorothiazide) For Treatment Of High Blood Pressure
Tue, 02 May 2006 06:00 AM EST
... The U.S. Food and DrugAdministration (FDA) approved two new, higher dose formulations of the highblood pressure medication Diovan HCT(R) (valsartan/hydrochlorothiazide):320/12.5 mg and 320/25 mg. The approval of the higher strengths of DiovanHCT provides more options to help physicians more effectively manage theirpatients' high blood pressure... click link for more info. ...
Related Topics
- Valsartan
- Valsartan and Hydrochlorothiazide
- Hypertension
- Low Blood Pressure
- Blood Pressure
- Olmesartan
- Hydrochlorothiazide
- High Cholesterol
- Telmisartan and Hydrochlorothiazide
- Olmesartan and Hydrochlorothiazide
- High Blood Pressure and Kidney Disease
- Benazepril and Hydrochlorothiazide
- Blood Pressure, High
- Candesartan and Hydrochlorothiazide
- High blood pressure (hypertension)
- Hypertension/High Blood Pressure
- Medications
- Metoprolol and Hydrochlorothiazide
- Fosinopril and Hydrochlorothiazide
- Medication
email this page
print this page
bookmark this page
feedback on this page
